SUBSTITUTED TRICYCLIC COMPOUNDS AS FGFR INHIBITORS

摘要

The present invention relates to tricyclic compounds, and pharmaceutical compositions of the same, that are inhibitors of one or more FGFR enzymes and are useful in the treatment of FGFR-associated diseases such as cancer.